These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4919352)

  • 1. Concentration of homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other dyskinesias.
    Papeschi R; Molina-Negro P; Sourkes TL; Hardy J; Bertrand C
    Neurology; 1970 Oct; 20(10):991-5. PubMed ID: 4919352
    [No Abstract]   [Full Text] [Related]  

  • 2. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA; Roos BE
    Confin Neurol; 1972; 34(2):136-42. PubMed ID: 4579783
    [No Abstract]   [Full Text] [Related]  

  • 3. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
    Rinne UK; Sonninen V
    Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of spinal fluid homovanillic acid (HVA) in patients with diseases of the nervous system.
    Mones RJ; Wilk S; Green J; Jutkowitz R
    Mt Sinai J Med; 1972; 39(5):478-85. PubMed ID: 4538762
    [No Abstract]   [Full Text] [Related]  

  • 5. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA; Roos BE
    Confin Neurol; 1972; 34(1):136-42. PubMed ID: 4538913
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of stereotaxic treatment of Parkinson's syndrome and involuntary movements].
    Sierpiński S; Mempel E; Pilipowska T
    Neurol Neurochir Pol; 1967; 17(1):61-6. PubMed ID: 5337233
    [No Abstract]   [Full Text] [Related]  

  • 7. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
    Tabaddor K; Wolfson LI; Sharpless NS
    Neurology; 1978 Dec; 28(12):1249-53. PubMed ID: 569783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
    Chase TN; Schnur JA; Gordon EK
    Neuropharmacology; 1970 May; 9(3):265-8. PubMed ID: 5424003
    [No Abstract]   [Full Text] [Related]  

  • 9. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Erba G
    Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereotaxic brain operations in Parkinson's syndrome and related motor disturbances. Comparison of lesions in the pallidum and thalamus with those in the internal capsule.
    Levy A
    Confin Neurol; 1967; 29():Suppl:1-70. PubMed ID: 4865921
    [No Abstract]   [Full Text] [Related]  

  • 11. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
    Bernheimer H; Birkmayer W; Hornykiewicz O
    Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
    Voto Bernales J; Cruz GA; Davila E
    Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Homovanillic acid concentration of the cerebrospinal fluid in epilepsy].
    Kobayashi K; Ebara Y; Hosokawa K; Oku Y
    No To Shinkei; 1976 Apr; 28(4):371-7. PubMed ID: 829031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebral mediators and intracranial neoplasms].
    Collice M; Porta M; Ferrara M; Castelli A
    Acta Neurol (Napoli); 1975; 30(1):71-7. PubMed ID: 1225028
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences with sterotactic operations for Parkinson's disease.
    van Manen J
    Psychiatr Neurol Neurochir; 1968; 71(1):77-83. PubMed ID: 4879826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stereotaxic operations on the brain].
    Kessel FK
    Ther Ggw; 1974 May; 113(5):738-53. PubMed ID: 4603845
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):704-10. PubMed ID: 4210686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryogenic thalamotomy in Parkinson's disease.
    Bell DS; Bleazel K
    Med J Aust; 1967 Sep; 2(11):500-5. PubMed ID: 4862309
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryogenic thalamotomy in Parkinson's disease.
    Bell S; Bleazel K
    Med J Aust; 1967 Sep; 2(11):500-5. PubMed ID: 4861465
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
    Johannsson B; Roos BE
    Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.